Home Ortho Clinical Diagnostics

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics Receives 2nd Antibody CE Mark

The company are trusted partners of hospitals, hospital networks, blood banks, and labs around the world, serving the clinical laboratory and transfusion medicine communities with customized solutions that enhance clinical outcomes, improve lab performance, overcome staffing challenges and better manage costs.

Ortho Launches Second COVID-19 Antibody Test With 100% Specificity

This test is one of only a handful of antibody tests to be granted Emergency Use Authorization.  

Launch of VITROS® XT 3400 Chemistry System from Ortho Clinical Diagnostics

VITROS XT Solutions, which include the new VITROS XT 3400 Chemistry System and the VITROS® XT 7600 Integrated System with new XT MicroSlides, help ensure the right result the first time, expediting critical health information to clinicians who can make decisions faster and ultimately improve patient outcomes.

ORTHO™ Sera ID-MTS for Use on the ORTHO VISION® Analyzer Now FDA Cleared

During pre-transfusion testing, lab professionals routinely encounter complex patient samples that require extended antigen typing.

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark

By combining Ortho's proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously, Ortho is introducing digital chemistry to clinical lab management.

Ortho Clinical Diagnostics Launches Ortho’s VITROS® C-peptide Assay

3/9/18: Assay is now commercially available in the U.S. and countries accepting CE Mark